Tarsus Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TARS and other ETFs, options, and stocks.

About TARS

Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of therapeutic candidates. Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis. 

CEO
Bobak Azamian
CEOBobak Azamian
Employees
244
Employees244
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
2017
Founded2017
Employees
244
Employees244

TARS Key Statistics

Market cap
2.00B
Market cap2.00B
Price-Earnings ratio
-13.98
Price-Earnings ratio-13.98
Dividend yield
—
Dividend yield—
Average volume
447.41K
Average volume447.41K
High today
$54.28
High today$54.28
Low today
$52.38
Low today$52.38
Open price
$53.32
Open price$53.32
Volume
109.35K
Volume109.35K
52 Week high
$57.28
52 Week high$57.28
52 Week low
$20.08
52 Week low$20.08

Analyst ratings

89%

of 9 ratings
Buy
88.9%
Hold
11.1%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.